The SELECT trial: A multicenter phase II trial of adjuvant erlotinib (E) in patients with resected, early-stage non-small cell lung cancer (NSCLC) and confirmed mutations in the epidermal growth factor receptor (EGFR) Meeting Abstract
| Authors: | Pennell, N. A.; Neal, J. W.; Govindan, R.; Janne, P. A.; Evans, T. L.; Costa, D. B.; Rosovsky, R. P. G.; Lanuti, M.; Azzoli, C. G.; Sequist, L. V. |
| Abstract Title: | The SELECT trial: A multicenter phase II trial of adjuvant erlotinib (E) in patients with resected, early-stage non-small cell lung cancer (NSCLC) and confirmed mutations in the epidermal growth factor receptor (EGFR) |
| Meeting Title: | 47th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 29 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2011 Jun 3-7 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2011-05-20 |
| Language: | English |
| ACCESSION: | WOS:000208880304634 |
| DOI: | 10.1200/jco.2011.29.15_suppl.tps209 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: TPS209 -- Source: Wos |
